Kesler Norman & Wride LLC Acquires Shares of 4,902 Cardinal Health, Inc. $CAH

Kesler Norman & Wride LLC bought a new stake in shares of Cardinal Health, Inc. (NYSE:CAH) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 4,902 shares of the company’s stock, valued at approximately $1,007,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Calton & Associates Inc. purchased a new stake in Cardinal Health during the fourth quarter worth about $252,000. Natixis Advisors LLC boosted its stake in Cardinal Health by 19.6% in the fourth quarter. Natixis Advisors LLC now owns 521,251 shares of the company’s stock valued at $107,117,000 after acquiring an additional 85,590 shares during the last quarter. Beaton Management Co. Inc. bought a new position in shares of Cardinal Health during the 4th quarter valued at approximately $225,000. Crestmont Private Wealth LLC purchased a new stake in shares of Cardinal Health during the 4th quarter worth approximately $264,000. Finally, Root Financial Partners LLC lifted its stake in Cardinal Health by 19.3% in the fourth quarter. Root Financial Partners LLC now owns 557 shares of the company’s stock valued at $114,000 after purchasing an additional 90 shares during the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Price Performance

NYSE CAH opened at $196.17 on Thursday. The company’s 50 day simple moving average is $202.75 and its two-hundred day simple moving average is $208.62. Cardinal Health, Inc. has a 1 year low of $137.75 and a 1 year high of $233.60. The stock has a market capitalization of $45.95 billion, a PE ratio of 30.00, a P/E/G ratio of 1.16 and a beta of 0.52.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm had revenue of $60.94 billion during the quarter, compared to analyst estimates of $62.10 billion. During the same period in the previous year, the business earned $2.35 EPS. The business’s revenue for the quarter was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, research analysts anticipate that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be paid a $0.5158 dividend. The ex-dividend date is Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a yield of 1.1%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio is currently 31.19%.

Analysts Set New Price Targets

CAH has been the subject of a number of recent research reports. Wells Fargo & Company decreased their target price on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Wall Street Zen cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 30th. William Blair assumed coverage on Cardinal Health in a research note on Tuesday, April 28th. They set an “outperform” rating for the company. UBS Group set a $260.00 price objective on Cardinal Health and gave the company a “buy” rating in a research note on Friday, February 6th. Finally, TD Cowen upped their price target on shares of Cardinal Health from $251.00 to $255.00 and gave the company a “buy” rating in a research note on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and an average price target of $241.80.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.